The invention relates to thrombospondin fragments found in plasma, their use or use of portions thereof in diagnostic methods, as method calibrators, method indicators, and as immunogens, and as analytes for methods with substantial clinical utility； and their detection in plasma or other bodily fluids for purpose of diagnostic methods, especially for cancer.
